<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We aimed to identify and classify cases of paediatric <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) occurring in Britain to estimate the incidence of this rare group of diseases, investigate the results of therapy and identify prognostic risk factors </plain></SENT>
<SENT sid="1" pm="."><plain>Patients aged below 15 years at diagnosis were collected from England, Scotland and Wales, inclusively between 1990 and 1999 </plain></SENT>
<SENT sid="2" pm="."><plain>One hundred and thirty-five patients were accepted as de novo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> or juvenile <z:mpath ids='MPATH_501'>myelomonocytic leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JMML</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>The incidence for this period was 1.35 per million (age standardized rate) which is below that reported outside the UK </plain></SENT>
<SENT sid="4" pm="."><plain>The overall survival was 45%[standard error (SE) = 4%] at 5 years: 40% (SE = 6%) for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JMML</z:e> and 50% (SE = 6%) for other <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Significant adverse prognostic factors for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JMML</z:e> were a platelet count &lt; 40 x 10(9)/l, raised fetal <z:chebi fb="34" ids="35143">haemoglobin</z:chebi>, FPC score and age above 2 years at diagnosis, for other <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> only <z:mp ids='MP_0004026'>monosomy</z:mp> 7 was significant </plain></SENT>
<SENT sid="6" pm="."><plain>To conclude, the incidence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JMML</z:e> in children in the UK appears to be lower than that reported outside the UK </plain></SENT>
<SENT sid="7" pm="."><plain>This may be either a real difference in incidence or variation in reporting </plain></SENT>
<SENT sid="8" pm="."><plain><z:mp ids='MP_0004026'>Monosomy</z:mp> 7 is associated with poor outcome in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> other than <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JMML</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>The prognosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JMML</z:e> depends on age, platelet count and fetal <z:chebi fb="34" ids="35143">haemoglobin</z:chebi> </plain></SENT>
</text></document>